The Deputy Commissioner of Kohima, B Henok Buchem, NCS, has issued an order reinforcing regulations on the sale of restricted drugs in the district. This directive continues the order issued on April 19, 2023, and aligns with the Drugs and Cosmetics Act, 1940, as amended through Gazette Notification GSR 588(E), dated August 30, 2023, along with Rule 65 of the Drugs and Cosmetics Rules, 1945.
According to the new order, all pharmacies and medical stores in Kohima must comply with the following regulations:
Sale of Schedule ‘X’, ‘H’, and ‘H1’ Drugs: These restricted drugs shall only be sold upon presentation of a valid prescription from a registered medical practitioner and only in the quantity specified.
Record Maintenance: Pharmacies are required to maintain a register documenting all sales of the aforementioned drugs, including details of the prescriber, patient, drug, and quantity sold. These records must be preserved for three years and made available for inspection upon request.
CCTV Footage Inspection: In compliance with the National Commission for Protection of Child Rights (NCPCR) Joint Action Plan, the District Drug Controller Authority and the District Enforcement Force, Kohima, will inspect CCTV footage from the last two months to monitor transactions and ensure compliance.
Non-compliance with these directives will lead to penal action under Section 152 of the Bharatiya Nyaya Sanhita (BNSS), Section 28A of the Drugs and Cosmetics Act, 1940, and other applicable legal provisions.
All pharmacies and medical stores have been instructed to strictly adhere to these regulations to ensure compliance with the law and prevent the misuse of restricted drugs.
Great advice! I’ll definitely be implementing some of these tips.